
Valrest 250mg Tablet ER
Marketer
SBS Biotech Limited
Salt Composition
Valproic Acid (250mg)
Overview Valrest 250mg Tablet ER
Epilepsy, bipolar disorder, and migraine prevention are addressed by the extended-release Valrest 250mg tablet. Its mechanism involves neural calming, promoting brain relaxation. Administration may coincide with or precede meals, ideally at a consistent daily time. Dosage and treatment duration should adhere to your physician's instructions. Missed doses should be taken promptly upon recollection. Consistent medication use is vital; premature cessation, without consulting your doctor, risks increased seizure activity. Potential side effects include headache, visual disturbances, appetite changes, nausea, vomiting, alopecia, and diarrhea. Drowsiness and dizziness may occur, necessitating caution regarding driving or tasks demanding concentration. Weight gain is possible; a balanced diet and exercise regimen are recommended for mitigation. Consult your doctor concerning persistent or bothersome side effects.
Primary Ingredients of Valrest 250mg Tablet ER
No text was provided to rewrite.
Uses of Valrest 250mg Tablet ER
Management of Epilepsy and Seizures | Migraine Prophylaxis | Bipolar Disorder Treatment
Major Benefits of Valrest 250mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Valrest 250mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Valrest 250mg Tablet ER:
- Headache
- Dizziness
- Blurred vision
- Loss of appetite
- Nausea
- Vomiting
- Sleepiness
- Hair loss
- Weight gain
- Tremors
- Double vision
- Diarrhea
- Impaired coordination
- Increased appetite
- Weakness
- Stomach pain
How to use Valrest 250mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 250mg Valrest Extended-Release tablet whole; do not break, crush, or chew it. Administer this medication with a meal.
How Valrest 250mg Tablet ER works:
Valrest 250mg Extended-Release tablets are used to manage epilepsy. This anticonvulsant medication works by reducing heightened, irregular neuronal firing in the brain, thereby controlling seizures.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Valrest 250mg Extended-Release Tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Valrest 250mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Valrest 250mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Extended-release Valrest 250mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should use Valrest 250mg Extended-Release tablets cautiously. Dosage modification of Valrest 250mg Extended-Release tablets may be necessary. Physician consultation is advised for patients with pre-existing kidney conditions.
LiverUNSAFE
Individuals with hepatic impairment should not take Valrest 250mg Extended-Release tablets; this medication is contraindicated in such cases. Medical advice is necessary before use. Valrest 250mg Extended-Release tablets are unsuitable for patients experiencing severe or active liver disease.
What if you forget to take Valrest 250mg Tablet ER :
Should you forget a Valrest 250mg Extended-Release Tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Valrest 250mg Tablet ER
| Label | Value |
|---|---|
| Chemical Classification | Valproate |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Class | Antiepileptic drugs targeting sodium channels |
